A new trading day began on Friday, with Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) stock price down -6.15% from the previous day of trading, before settling in for the closing price of $18.21. TNXP’s price has ranged from $6.76 to $72.00 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 73.03%. Meanwhile, its annual earnings per share averaged 92.40%. With a float of $11.77 million, this company’s outstanding shares have now reached $11.78 million.
Tonix Pharmaceuticals Holding Corp (TNXP) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.04%, while institutional ownership is 20.09%. The most recent insider transaction that took place on Aug 21 ’25, was worth 15,061. In this transaction Director of this company bought 418 shares at a rate of $36.03, taking the stock ownership to the 418 shares. Before that another transaction happened on Aug 20 ’25, when Company’s Director bought 250 for $36.00, making the entire transaction worth $9,000. This insider now owns 250 shares in total.
Tonix Pharmaceuticals Holding Corp (TNXP) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 92.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 74.04% during the next five years compared to 73.03% growth over the previous five years of trading.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
Here are Tonix Pharmaceuticals Holding Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 9.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -986.99, a number that is poised to hit -3.19 in the next quarter and is forecasted to reach -7.80 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Looking closely at Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP), its last 5-days average volume was 0.47 million, which is a drop from its year-to-date volume of 1.23 million. As of the previous 9 days, the stock’s Stochastic %D was 9.69%.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 6.02%, which indicates a significant decrease from 36.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.33 in the past 14 days, which was lower than the 2.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.01, while its 200-day Moving Average is $26.98. However, in the short run, Tonix Pharmaceuticals Holding Corp’s stock first resistance to watch stands at $18.14. Second resistance stands at $19.18. The third major resistance level sits at $19.74. If the price goes on to break the first support level at $16.54, it is likely to go to the next support level at $15.98. Now, if the price goes above the second support level, the third support stands at $14.94.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
With a market capitalization of 201.26 million, the company has a total of 11,777K Shares Outstanding. Currently, annual sales are 10,090 K while annual income is -130,040 K. The company’s previous quarter sales were 3,290 K while its latest quarter income was -32,010 K.
